Development of Recombinant Antibody by Yeast Surface Display Technology

Overview

Journal Curr Res Pharmacol Drug Discov

Date 2024 Feb 6

PMID 38318280

Authors

Mujahed I Mustafa

Awad A Alzebair

Ahmed Mohammed

Affiliations

Soon will be listed here.

Abstract

Recombinant antibodies have emerged as powerful tools in various fields, including therapeutics, diagnostics, and research applications. The selection of high-affinity antibodies with desired specificity is a crucial step in the development of recombinant antibody-based products. In recent years, yeast surface display technology has gained significant attention as a robust and versatile platform for antibody selection. This graphical review provides an overview of the yeast surface display technology and its applications in recombinant antibody selection. We discuss the key components involved in the construction of yeast surface display libraries, including the antibody gene libraries, yeast host strains, and display vectors. Furthermore, we highlight the strategies employed for affinity maturation and optimization of recombinant antibodies using yeast surface display. Finally, we discuss the advantages and limitations of this technology compared to other antibody selection methods. Overall, yeast surface display technology offers a powerful and efficient approach for the selection of recombinant antibodies, enabling the rapid generation of high-affinity antibodies for various applications.

Citing Articles

Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.

Liu J, Wu L, Xie A, Liu W, He Z, Wan Y J Nanobiotechnology. 2025; 23(1):87.

PMID: 39915791 PMC: 11800653. DOI: 10.1186/s12951-025-03169-5.

Optimized single-cell gates for yeast display screening.

Pan X, de Souza M, Figueiras F, Huang A, Banach B, Wolfe J Protein Eng Des Sel. 2024; 38.

PMID: 39667035 PMC: 11723770. DOI: 10.1093/protein/gzae018.

A yeast surface display platform for screening of non-enzymatic protein secretion in Kluyveromyces lactis.

An J, Shang N, Liu W, Niu Y, Liang Q, Jiang J Appl Microbiol Biotechnol. 2024; 108(1):503.

PMID: 39500795 PMC: 11538148. DOI: 10.1007/s00253-024-13342-9.

References

Frenzel A, Hust M, Schirrmann T . Expression of recombinant antibodies. Front Immunol. 2013; 4:217. PMC: 3725456. DOI: 10.3389/fimmu.2013.00217. View

Tanaka T, Kondo A . Cell-surface display of enzymes by the yeast Saccharomyces cerevisiae for synthetic biology. FEMS Yeast Res. 2014; 15(1):1-9. DOI: 10.1111/1567-1364.12212. View

Hoogenboom H . Selecting and screening recombinant antibody libraries. Nat Biotechnol. 2005; 23(9):1105-16. DOI: 10.1038/nbt1126. View

Mumberg D, Muller R, Funk M . Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene. 1995; 156(1):119-22. DOI: 10.1016/0378-1119(95)00037-7. View

Cherf G, Cochran J . Applications of Yeast Surface Display for Protein Engineering. Methods Mol Biol. 2015; 1319:155-75. PMC: 4544684. DOI: 10.1007/978-1-4939-2748-7_8. View

Chao G, Lau W, Hackel B, Sazinsky S, Lippow S, Wittrup K . Isolating and engineering human antibodies using yeast surface display. Nat Protoc. 2007; 1(2):755-68. DOI: 10.1038/nprot.2006.94. View

Tanaka T, Yamada R, Ogino C, Kondo A . Recent developments in yeast cell surface display toward extended applications in biotechnology. Appl Microbiol Biotechnol. 2012; 95(3):577-91. DOI: 10.1007/s00253-012-4175-0. View

Boder E, Wittrup K . Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol. 1997; 15(6):553-7. DOI: 10.1038/nbt0697-553. View

Drago J, Modi S, Chandarlapaty S . Unlocking the potential of antibody-drug conjugates for cancer therapy. Nat Rev Clin Oncol. 2021; 18(6):327-344. PMC: 8287784. DOI: 10.1038/s41571-021-00470-8. View

10.

Konning D, Kolmar H . Beyond antibody engineering: directed evolution of alternative binding scaffolds and enzymes using yeast surface display. Microb Cell Fact. 2018; 17(1):32. PMC: 6389260. DOI: 10.1186/s12934-018-0881-3. View

11.

Gera N, Hussain M, Rao B . Protein selection using yeast surface display. Methods. 2012; 60(1):15-26. DOI: 10.1016/j.ymeth.2012.03.014. View

12.

Wang Y, Peterson S, Loring J . Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res. 2013; 24(2):143-60. PMC: 3915910. DOI: 10.1038/cr.2013.151. View

13.

McMahon C, Baier A, Pascolutti R, Wegrecki M, Zheng S, Ong J . Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat Struct Mol Biol. 2018; 25(3):289-296. PMC: 5839991. DOI: 10.1038/s41594-018-0028-6. View

14.

Boder E, Raeeszadeh-Sarmazdeh M, Price J . Engineering antibodies by yeast display. Arch Biochem Biophys. 2012; 526(2):99-106. DOI: 10.1016/j.abb.2012.03.009. View

15.

Teymennet-Ramirez K, Martinez-Morales F, Trejo-Hernandez M . Yeast Surface Display System: Strategies for Improvement and Biotechnological Applications. Front Bioeng Biotechnol. 2022; 9:794742. PMC: 8784408. DOI: 10.3389/fbioe.2021.794742. View

16.

Pavlickova P, Schneider E, Hug H . Advances in recombinant antibody microarrays. Clin Chim Acta. 2004; 343(1-2):17-35. DOI: 10.1016/j.cccn.2004.01.009. View

17.

Saeed A, Wang R, Ling S, Wang S . Antibody Engineering for Pursuing a Healthier Future. Front Microbiol. 2017; 8:495. PMC: 5368232. DOI: 10.3389/fmicb.2017.00495. View

18.

Gai S, Wittrup K . Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol. 2007; 17(4):467-73. PMC: 4038029. DOI: 10.1016/j.sbi.2007.08.012. View

19.

Linciano S, Pluda S, Bacchin A, Angelini A . Molecular evolution of peptides by yeast surface display technology. Medchemcomm. 2019; 10(9):1569-1580. PMC: 6836575. DOI: 10.1039/c9md00252a. View

20.

Kim H, Yoo S, Kang H . Yeast synthetic biology for the production of recombinant therapeutic proteins. FEMS Yeast Res. 2014; 15(1):1-16. DOI: 10.1111/1567-1364.12195. View